The Livingston, N.J.-based company developed CompuFlo Epidural to use dynamic pressure sensing to help anesthesiologists correctly identify the epidural space and reduce complications in real-time.
The system also has 510(k) clearance in the U.S.
“Receiving a medical device license in Canada is another important step in our global roll-out strategy. Over the past year, we have been primarily focused on building relationships with key opinion leaders around the world,” interim CEO Leonard Osser said in prepared remarks.
“At the same time, we are lining up distributors in major markets throughout North America and Europe. Importantly, we expect to see the results of our trials published in leading industry journals later this year, which should help further accelerate our commercial rollout,” he added.
In November last year, Milestone Scientific revealed its plans to launch a cosmetic injection instrument designed to deliver botulinum toxin.